The Israeli Society for Research, Prevention & Treatment of Atherosclerosis
|
|
|
- Virgil McCormick
- 5 years ago
- Views:
Transcription
1 הה תדרות הרפואית בישראל - החברה לחקר, מניעה וטיפול בטרשת העורקימ Israel Medical Association - Society for Research, Prevention and Treatment of Atherosclerosis The 21th Annual Meeting The Israeli Society for Research, Prevention & Treatment of Atherosclerosis in association with the Working Group on Epidemiology and Prevention-Israel Heart Society. Dan-Carmel Hotel, Haifa, Israel October 27-30,
2 SCIENTIFIC PROGRAM THURSDAY, 27 October :00-10:30 10:30-11:00 11:00-13:30 Registration Welcome Ronen Durst, President of the Israeli Society for Research, Prevention and Treatment of Atherosclerosis Bianca Fuhrman: Head of the Scientific Committee Session 1: Vascular Biology in Atherosclerosis and Metabolic Disease Paraoxonase (PON) protection against Atherogenesis Michael Aviram - Technion Faculty of Medicine, Israel Paraoxonase - 1 reduce vasodilation in the microcirculation by regulating the arachidonic acid lactone metabolite Andrea Szuchman-Sapir - MIGAL- Galilee Research Institute, Israel A novel lysosome-dependent mechanism for the treatment of diet-induced metabolic diseases Zemin Yao - University of Ottawa, Canada A possible crosstalk between human carotid plaque and blood components Yacov Vaya - MIGAL- Galilee Research Institute, Israel Fructose restriction lowers apoc-iii levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome Alejandro Gugliucci - Touro University-California, USA The synergistic anti-inflammatory effect of EPA, Lycopene, Carnosic acid and Lutein combinations via inhibition of NF-kB and CREB signaling in activated microglia. Rachel Levy - Ben-Gurion University, Israel 13:30-14:30 Lunch Break, Exhibition and Poster Viewing 14:30-16:30 Session 2: Development, Progression and Sequelae of Non-Alcoholic Fatty Liver Disease Chairpersons: Yehuda Kamari, tba On the machanisms driving NASH and subsequent HCC: Metabolic immune activation is key Mathias Heikenwälder - Helmholtz Zentrum Muenchen, Germany Is there a specific treatment for NAFLD? Hilla Knobler - Kaplan Medical Center, Israel Is liver lipotoxicity due to Triglycerides or to Cholesterol? Yehuda Kamari - Sheba Medical Center, Israel Angry fat and Fatty Liver in obesity: who are the mediators? Assaf Rudich - Ben-Gurion University, Israel Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk Osama Hussein - Ziv Medical Center, Israel 16:30-17:00 Coffee Break, Exhibition and Poster Viewing 2
3 17:00-19:30 Session 3: Dyslipidemias and Atherosclerosis: Advances in Diagnosis and Treatment Chairpersons: Eran Leitersdorf, tba Keynote Lecture The saga of PCSK9 and its LDL regulation: from bench to bedside Nabil Seidah - Clinical Research Institute of Montreal, Canada Four decades of research in Familial Hypercholesterolemia: Success and failure in drug development Eran Leitersdorf - Hadassah Hebrew University, Israel Clinical determinants and treatment gaps in Familial Hypercholesterolemia: Data from a Single District in Israel Barak Zafrir - Carmel Medical Center, Israel FH in Israel 2016: Data of Clalit Health Services Avishay Elis - Rabin Medical Center, Israel Peripheral blood progenitor cells in hyperlipidaemia: The effect of hypolipidaemic therapy Alexandros Tselepis - University of Ioannina, Greece Dinner FRIDAY, 28 October :00-08:30 08:30-09:00 09:00-11:00 Registration Welcome Rafael Bitzur, Secretary of Israel Society for Research, Prevention and Treatment of Atherosclerosis Session 4: Vascular Biology of Atherosclerosis The regression of atherosclerosis: new treatments on the horizon Edward A. Fisher - NYU School of Medicine, USA Nuclear control of lipid homeostasis Peter Tontonoz - University of California, Los Angeles, USA The pathogenesis of atherosclerosis: a triumph of simplicity! Kevin J. Williams - Temple University School of Medicine, USA Lp(a) : Coming of Age--At Last Joseph Witztum - University of California, San-Diego, USA 11:00-11:30 Coffee Break, Exhibition and Poster Viewing 3
4 11:30-13:30 Parallel Sessions 5 and 6 Session 5: New Risk Factor and Atherosclerosis Imaging for Recategorization of CV Risk In cooperation with the Working Group on Epidemiology and Prevention Israel Heart Association Chairpersons: Uri Goldbourt, Joseph Shemesh Keynote Lecture Cardiovascular risk assessment: Past, Present, and Future. Philip Greenland - Northwestern University, USA Estimating coronary risk in disease-free individuals: What have we learned? Uri Goldbourt - Tel Aviv University, Israel Coronary calcium score for restratification of CV risk: The MESA Score. Joseph Shemesh - Tel-Aviv University, Israel 3-D ultrasound for atherosclerosis imaging: Measuring the total burden of atherosclerosis for disease screening Salo Haratz - Sheba Medical Center, Israel Biomarkers, imaging and functional tests in reclassification of CV risk Rafael Bitzur - Sheba Medical Center, Israel Session 6: Nutrition in Health and Disease In cooperation with ATID-Israeli Dietetic Association Protective role of monounsaturated fatty acids against nutrient overload in pancreatic beta cells Shlomo Sasson Hadassah Hebrew University, Israel Pro-atherogenic effects of linoleic acid-rich soybean oil: studies in mice and cultured macrophages Oren Rom - Technion Faculty of Medicine, Israel Maternal dietary fatty acids quality plays a significant role during fetal programming resulting in long term differential effects as health or disease in the offspring Alicia Leikin Frenkel - Sheba Medical Center, Israel Myths in cardiovascular nutrition:excerpts from the Israeli Dietary Guidelines Yacov Henkin - Ben-Gurion University, Israel 13:30-14:30 Lunch Break, Exhibition and Poster Viewing 14:30-16:30 Session 7: Panel Discussion: Challenging Case Studies in Hyperlipidemia Moderators: Rafael Bitzur, tba Shabbat Dinner 4
5 SATURDAY, 29 October :30-19:00 Poster Session Moderators: tba 19:00-19:10 Tribute to Prof. Ardon Rubinstein 19:10-19:20 Awards 20:30-20:00 Keynote Lecture New Insights into the Actions of Statins in Atherogenic Dyslipidemia: Metabolomics John Chapman - INSERM at the Pitié-Salpétrière Hospital, France 20:30 Dinner 5
Sunday, March 22, 2015
SCIENTIFIC PROGRAMME (As of October 7, 2014) Sunday, March 22, 2015 12:00-13:30 Educational Symposium - Supported Session 12:00-13:30 Educational Symposium - Supported Session Hall B 13:30-14:00 Break
Saturday, 8 September 2018 Treatment options and update on statin treatment Chair: M. Kayikcioglu, V. Kotsis How far should we lower LDL?
Friday, 7 September 2018 11.00-11.45 Registrations 11.45-12.00 Introduction - Welcome Messages L. Tokgozoglu, V. Kotsis Atherosclerosis and cardiovascular risk update Chair: A. Tselepis, H. Kultursay 12.00-12.30
April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, rd International Congress on Molecular Targeting Therapy
3 rd International Congress on Molecular Targeting Therapy April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, 2017 Update: Mar. 12 14:00-21:00 Registration & Check-In 16:00-17:00
ISRAELI NEUROENDOCRINE TUMORS PROGRAM
1 rd THE 3 ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 22.09.2016-24.09.2016 Crown Plaza Hotel, The Dead Sea PROGRAM Thursday, 22.09.2016 15:00-15:30 Registration 15:30-15:50 Opening Remarks 15:50-16:50
Prof. John Chapman, MD, PhD, DSc
Prof. John Chapman, MD, PhD, DSc Director of the Dyslipidemia and Atherosclerosis Research Unit of the National Institute for Health and Medical Research (INSERM) at the Pitié-Salpétrière Hospital in Paris
Best Lipid Treatments
Best Lipid Treatments Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Overview of Talk Review of pathogenesis
ISRAELI NEUROENDOCRINE TUMORS PROGRAM
th THE 4 1 ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks 15:50-16:50
THURSDAY, 30 JUNE, 2016 FRIDAY, 1 JULY 2016
THURSDAY, 30 JUNE, 2016 18:00 18:30 OPENING CEREMONY Opening Lecture: TBA 18:30 19:30 Chairs: Maciej Banach (); Nathan D. Wong (Irvine, USA) 19:30 Get Together Reception FRIDAY, 1 JULY 2016 08:30 - Plenary
XIV Anual Scientific Meeting I International Meeting Argentine Society of Lipids - International Atherosclerosis Society
XIV Anual Scientific Meeting I International Meeting Argentine Society of Lipids - International Atherosclerosis Society Chemistry, biology, genetic: two decades Hotel Abasto, Argentina September 14 th
PCSK9 Inhibitors and Modulators
PCSK9 Inhibitors and Modulators Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Disclosures Speaker s
FRIDAY, JUNE 21. Epidemiology/ Genetics. Symposium The Big Picture Genetic Architecture of Diabetes Room S 103 B
Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. FRIDAY, JUNE 21 Noon 12:40 p.m. Meet the Expert Sessions 12:50 p.m. 1:30 p.m. Meet the Expert Sessions 2:00 p.m. 4:00 p.m.
2018 Kern Lipid Conference
2018 Kern Lipid Conference Metabolic Regulation of Immunity, Cardiometabolic Diseases and Cancer: New Therapeutic Approaches Monday, August 13, 2018 to Wednesday, August 15, 2018 - Vail, Colorado Organizers:
Program Agenda. Ottawa Heart Research Conference (OHRC): Steadying the Future of Atrial Fibrillation. Thursday, June 2 nd (Day 1)
Ottawa Heart Research Conference (OHRC): Steadying the Future of Atrial Fibrillation Thursday, June 2 nd (Day 1) 8:00 am Welcome Message Drs. David Birnie, Peter Liu, and Thierry Mesana 8:15 9:35 am Session
Familial hypercholesterolaemia in children and adolescents
Familial hypercholesterolaemia in children and adolescents Rationale and recommendations for early identification and treatment European Atherosclerosis Society Consensus Panel Slide deck adapted from:
9th Annual Orange County Symposium on Cardiovascular Disease Prevention
The Division of Cardiology, Department of Medicine, UC Irvine School of Medicine Presents the 9th Annual Orange County Symposium on Cardiovascular Disease Prevention Future Directions in Prevention of
October 25-26, 2018 Infinity Hotel & Conference Resort, Munich, Germany
Programme 4 th CVOT Summit in cooperation with D&CVD EASD Study Group October 25-26, 2018 Infinity Hotel & Conference Resort, Munich, Germany Thursday, October 25, 2018 Room Ammersee I 18:00 18:30 Welcome,
THE BENEFITS THE PARTNERS WHAT IS IMMUNOTHERAPY? HOW WILL IT WORK? WHY CANCER RESEARCH INSTITUTE? WHY ISRAEL CANCER RESEARCH FUND?
A groundbreaking, collaborative campaign bringing together the Cancer Research Institute, the leading nonprofit funder of immunotherapy research internationally, with the Israel Cancer Research Fund, North
PRELIMINARY PROGRAM. 14:10-15:00 Session I: My Personal Experience CT/MR Chair: Herbert Frank Tulln, Austria Udo Hoffmann Boston, USA
PRELIMINARY PROGRAM Thursday 5 October 2017 14:00 Welcome 14:10-15:00 Session I: My Personal Experience CT/MR Chair: 14:10 14:35 Tips and Tricks CMR Holger Thiele Leipzig, Germany 14:35 15:00 Tips and
33 rd Annual Meeting of the Israel Society of Dermatology and Venereology Meridian Hotel, Dead Sea, Israel, June 16-17, 2010
First Announcement and Call for Papers Dear Colleagues, The Department of of Soroka University Medical Center, takes great pleasure to invite you to attend the 33rd Annual Meeting of the Israel Society
Crown Plaza Hotel, the Dead Sea PROGRAM
1 THE 4 th ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks: Dr. Simona
Coronary Tomography Angiography A. Gutstein, A. Wolak, V. Cheng, I. Cohen, J. Friedman, L. Thomson, S. Hayes, D.S. Berman Los Angeles
Thursday, April 23, 2009 08:30-10:00 S19 - Nuclear Cardiology and Cardiac CT - II Chairs: M. Moriel A. Solodky Hall H 08:30 A Novel Low-Dose CT Attenuation Correction Device Mounted on a Dedicated Cardiac
Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACC/AHA. See American College of Cardiology/ ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors American College of Cardiology/American
EAS Congress Innsbruck Highlights: A programme to excite, inspire and inform!
Press release 84 th European Atherosclerosis Society Congress, Innsbruck, Austria For circulation 29 th May, 2016. 84 th Annual Congress of the European Atherosclerosis Society (EAS) May 29 th - June 1
Lipid Lowering in Patients at High Risk for Cardiovascular Disease
Lipid Lowering in Patients at High Risk for Cardiovascular Disease Prof. John J.P. Kastelein, MD PhD FESC Dept. of Vascular Medicine Academic Medical Center / University of Amsterdam The Netherlands Novel
Density Lipoprotein (HDL) and Corneal Opacity Caused by Lecithin-Cholesterol
low Levels of High Density Lipoprotein (HDL) and Corneal Opacity Caused by Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency Mordechai Golomb 1, Rafael Bitzur 2, Eran Leitersdorf 1,Shoshi Shpitzen
INTERNATIONAL WORKSHOP ON MANAGEMENT OF END STAGE LIVER DISEASE DUE TO NASH WASHINGTON DC, USA 6-7 OCTOBER 2016 MEETING PROSPECTUS www.expertmedicalevents.com www.expertmedicalevents.com INTRODUCTION NAFLD
Tel Aviv, Israel July 1-3, Invitation for the Industry. Last Update: Ancient mosaic from the Sea of Galilee.
Tel Aviv, Israel July 1-3, 2014 Support and Exhibition Invitation for the Industry Last Update: 18.3.2013 Ancient mosaic from the Sea of Galilee www.comtecmed.com/foiu CO-CHAIRPERSONS Invitation for the
Coordinators of the Summer School. President of the Hellenic Atherosclerosis Society
SCIENTIFIC PROGRAM Thursday, June 29 t h, 2017 15.00 15.45 Registration desk open 15.45 16.00 Welcome address E. Liberopoulos K. Tziomalos Coordinators of the Summer School Welcome address C. Pitsavos
First World Conference on Targeting Liver Diseases June 26-27, 2014 Hadassah Medical Center Jerusalem, Israel
Scientific Program www.targeting-liver.com Dear Colleagues, It is a great pleasure to welcome you for the First World Conference on : Sciences, Clinical Innovation & Biotechnology to be held in Jerusalem
Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins
Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean
Vitiligo & Pigmentary Disorders Masterclass. Vitiligo Research Foundation & Israel Society of Dermatology & Venerology. Tel Aviv. November 25-26, 2015
Vitiligo & Pigmentary Disorders Masterclass Vitiligo Research Foundation & Israel Society of Dermatology & Venerology Tel Aviv. November 25-26, 2015 Scientific Program Dear friends, dear colleagues, On
Pathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE
PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE Thursday 17 th October, 2013 09.00- : Executive meetings (only for the Executive and the International Advisory Boards of EURIPA and the Executive of EGPRN),
June 4 th - 6 th 2014 Milazzo, Italy. 3 rd Workshop on Synaptic Plasticity: from bench to bedside
June 4 th - 6 th 2014 Milazzo, Italy 3 rd Workshop on Synaptic Plasticity: from bench to bedside WELCOME Dear Colleagues and Friends, We welcome you to the 3rd Workshop on Synaptic Plasticity: from bench
Finnish Atherosclerosis Society Suomen Ateroskleroosiyhdistys ry
19.2.2017 program Finnish Atherosclerosis Society Suomen Ateroskleroosiyhdistys ry Time: Friday 17.3.2017 Photograph by Hannu Uusitalo Place: The lecture hall of the Department of Pharmacology F202, Door
Memorial and Scientific Program
Memorial and Scientific Program Wednesday, September 13 18:00 Registration & Get together Institute of Pharmaceutical Sciences Humboldtstrasse 46, 8010 Graz Thursday, September 14 9:00 Esterbauer Memorial
Lipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
Core Curriculum for the Cardiovascular Clinician
September 14 17, 2016 Heart House Washington, DC AGENDA Wednesday, September 14 PHARMACOLOGY WORKSHOP 5:30 p.m. Registration and Light Refreshments 6:00 p.m. Welcome and Introductions 6:15 p.m. CVD Guideline-driven
ADVENTURES IN THE LIPIDOME
Organizing Committee: INTERNATIONAL SCHOOL OF PHARMACOLOGY ADVENTURES IN THE LIPIDOME Erice, Sicily, 26 th - 30 th September 2017 Garret FitzGerald, Philadelphia, USA Pietro Minuz, Verona, Italy Carlo
ISHNOS November Pastoral Hotel, Israel. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology
The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology ISHNOS 2018 www.ishnos.com Conference Secretariat Umbrella Events E-mail: umbrella.inquiry@gmail.com www.umbrella-events.com
PROGRAM RNA The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014
PROGRAM RNA 2014 The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014 (See room locations floor plan at the back of the book.) Tuesday June 3 14:00 20:00 Registration Foyer
Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source
Tools: Printer 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut along dashed lines Copyright Goodheart-Willcox Co., Inc. All rights reserved. Tissue in which the body
13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
RAISING THE BAR IN BREAST CANCER CARE
RAISING THE BAR IN BREAST CANCER CARE Multidisciplinary Approach in Breast Cancer October 26 th, 2018 Dan Hotel, Tel-Aviv HER2+ ER+ HER2- TNBC luminal B luminal A Joseph Gligorov, MD Professor of Medicine
CARDIOVASCULAR RISK REDUCTION
Jointly provided by the NYU Post-Graduate Medical School, the New York Chapter of the American College of Physicians and the Northeast Lipid Association Co-organized by the Division of Cardiology and the
Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source
Nutrition, Food, and Fitness Chapter 6 Fats: A Concentrated Energy Source Tools: Printer (color optional) 4 sheets of 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut
Preliminary PROGRAM. Thursday October 5, :00 Welcome Herbert Frank Tulln, AT. Session I: 14:10 15:00 MY PERSONAL EXPERIENCE CT/CMR
Preliminary PROGRAM Thursday October 5, 2017 14:00 Welcome Session I: 14:10 15:00 MY PERSONAL EXPERIENCE CT/CMR 14:10-14:35 Tips and Tricks CMR Holger Thiele Lübeck, DE 14:35-15:00 Tips and Tricks CT Matthias
Food, Microbiota and Immunity "For strong immunity - feed your microbiota well" June 7-10, 2017, Castle Třešť, Czech Republic
Food, Microbiota and Immunity "For strong immunity - feed your microbiota well" June 7-10, 2017, Castle Třešť, Czech Republic Program: Wednesday June 7 14:00 Departure from Prague by bus: station metro
Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
Research Article Evaluation of Family History, Antioxidant Intake and Activity Level as Indicators for Chronic Disease in A Healthy Young Population
Cronicon OPEN ACCESS NUTRITION Research Article Evaluation of Family History, Antioxidant Intake and Activity Level as Indicators for Chronic Disease in A Healthy Marcela Vergara-Jimenez 1, Amanda Missimer
International Society of Microbiota
Targeting Microbiota World Congress 2018 1 Targeting Microbiota World Congress 2018 2 Dear Colleagues, On behalf of the International Society of Microbiota, we are pleased to inform you that the 6th World
Steigmann Institute Israel Learn all about Soft Tissue Management Acquire Skills, Experience & Leisure
Learn all about Management Approved PACE Program Provider FAGD/MAGD Credit Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement 2/1/2016 to 1/31/2019 Provider
INC International Nut & Dried Fruit Council Symposium Nuts in Health and Disease. Granada, 19 th September 2013 Press Kit
INC International Nut & Dried Fruit Council Symposium Nuts in Health and Disease Granada, 19 th September 2013 Press Kit Index Introduction Keynote Speakers Conference Abstract Useful Information The International
Course Co- Chairmen Dr. Robert Allen, Dr. Nolan Karp, Dr. Steven Morris
2012 15 th International Perforator Flap Course Course Co- Chairmen Dr. Robert Allen, Dr. Nolan Karp, Dr. Steven Morris Honorary Course Chairman Dr. Joseph McCarthy NYU Faculty Christina Ahn, MD Robert
TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
EXCELLENCE IN SURGERY
International and Interdisciplinary Congress of the New European Surgical Academy on EXCELLENCE IN SURGERY PERUGIA, Italy April 19-20-21, 2018 Congress President and NESA Secretary General Gian Carlo Di
HCC and the Hallmarks of Cancer: steps towards novel therapeutic strategies
EASL HCC SUMMIT 2017 2-5 February 2017, Geneva, Switzerland Scientific Committee: Basic Programme: Tom Luedde, Germany Helen Reeves, United Kingdom Clinical Programme: Alejandro Forner, Spain Franco Trevisani,
EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS
EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS Nora Vigasini, Assistant Professor, Department of Home Science, Women s Christian College, Chennai, noravigas@gmail.com
Preliminary Scientific Program (last updated January 12, 2016) 17:30 Registration and Welcome Reception Dan Carmel Hotel, Haifa
SUNDAY, APRIL 3, 2016 Preliminary Scientific Program (last updated January 12, 2016) 17:30 Registration and Welcome Reception Dan Carmel Hotel, Haifa 19:00 OPENING REMARKS Dan Carmel Hotel, Haifa Karl
ESPE Science School (ESS) May 16-20, Heraklio, Crete, Greece
ESPE Science School (ESS) May 16-20, 2012 - Heraklio, Crete, Greece November 27, 2011 Dear ESPE member, RE: Call for ESS Student applications This is our annual call for ESPE members to have their younger
Danish Diabetes Academy
Danish Diabetes Academy Summer School on Diabetes & Metabolism - Scientific Programme 3-6 September, 2018 Sinatur Hotel Gl. Avernæs Helnæsvej 9, DK-5631 Ebberup Session overview Day 1 Monday September
Zuhier Awan, MD, PhD, FRCPC
Metabolism, Atherogenic Properties and Agents to Reduce Triglyceride-Rich Lipoproteins (TRL) The Fifth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 8-11, 2019 Zuhier
CNIO- la Caixa Foundation Frontiers Meeting- 2nd-4th MAY 2017 MOLECULAR CHAPERONES IN CANCER
Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain Chairpersons and organizing committee: Nabil Djouder, Spanish National Cancer Research Centre, Madrid, Spain Wilhelm Krek, Institute
18:00-19:00 Welcome Reception Exhibition Area
Thursday, February 28 th, 2019 14:00-18:00 Registration 18:00-19:00 Welcome Reception Exhibition Area Friday, March 1 st, 2019 09:00-11:10 Plenary Session 1: Opening Session Hall A Chairs: Stevo Julius,
Fatty acids and cardiovascular health: current evidence and next steps
Fatty acids and cardiovascular health: current evidence and next steps Emanuele Di Angelantonio, MD, PhD Department of Public Health and Primary Care NICE guidelines on fatty acids Eliminate the use of
B. Patient has not reached the percentage reduction goal with statin therapy
Managing Cardiovascular Risk: The Importance of Lowering LDL Cholesterol and Reaching Treatment Goals for LDL Cholesterol The Role of the Pharmacist Learning Objectives 1. Review the role of lipid levels
THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS
THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS Hormonal regulation INSULIN lipid synthesis, lipolysis CORTISOL lipolysis GLUCAGON lipolysis GROWTH HORMONE lipolysis CATECHOLAMINES lipolysis LEPTIN catabolism
Lipid/Lipoprotein Structure and Metabolism (Overview)
Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant
Insights from the Clalit Health Services database about Psoriasis Research using BIG DATA Arnon D. Cohen, MD, MPH, PHD
Insights from the Clalit Health Services database about Psoriasis Research using BIG DATA Arnon D. Cohen, MD, MPH, PHD Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences,
Hypertriglyceridemia, Inflammation, & Pregnancy
Hypertriglyceridemia, Inflammation, & Pregnancy Richard L. Nemiroff, MD, FACOG, NLA Professor, Clinical Gynecology Perelman School of Medicine University of Pennsylvania Philadelphia, PA Disclosure of
Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party
TIMETABLE Plenary Workshop Special Breaks Optional Event Educational Meet the expert INGID Working Party Wednesday 24 October 2018 I 08:30-09:00 Educational Lecture - Lymphoproliferation in PIDs 09:00-09:30
Friday, 22 nd September 2017
PROGRAM Friday, 22 nd September 2017 08:00-08:10 Welcome address and organizational issues Assoc. Prof. Paweł Płudowski, President of the Organizing Committee and Scientific Committee 08:10-11:10 1 st
2011 International Conference of Inflammation, Cancer and Metabolic Disorders Program
Friday, November 4 th, 2011 09:00-09:30 Registration 09:30-09:40 Welcome & Opening Remarks Kenneth K. Wu, M.D., Ph.D. Fu-Tong Liu, M.D., Ph.D. Plenary Lecture I Chair: Kenneth K. Wu, M.D., Ph.D. 09:40-10:40
Pattern of lipid biomarkers and risk of cardiovascular disease
Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,
Nordic-Baltic Region University Research Course Gdańsk, Poland, September 19-21, 2019
Nordic-Baltic Region University Research Course Gdańsk, Poland, September 19-21, 2019 HYPERTENSION AND CARDIOVASCULAR DISEASE: Focus on Brain, Cognition, Stroke and Sympathetic Nervous System Activity
SPR Annual Meeting & Postgraduate Course May 15-19, 2018
Tuesday, May 15, 2018 - Postgraduate Course 7:00 AM 8:00 AM Continental Breakfast 7:00 AM 5:30 PM Registration 7:50 AM 8:00 AM Course Overview Categorical Course Directors 8:00 AM 8:20 AM General Pediatric
Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az
Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of
M. Blich, M. Suleiman, T. Zeidan Shwiri, I. Marai, M. Boulos, S. Amikam Haifa
Thursday, April 23, 2009 16:00-17:30 S25 - Electrophysiology and Pacing Chairs: M. Eldar A. Militianu Hall D 16:00 Long Term Outcomes of VDD Mode Pacing in Patients with Atrioventricular Block M. Blich,
SYMPOSIUM ON INNOVATIVE CONCEPTS FOR TREATING NEURODEGENERATIVE DISEASES PROGRAMME September 2015
Day 0 Tuesday 22/09: 17:00-20:00 High school and Students Activities Time SYMPOSIUM ON INNOVATIVE CONCEPTS FOR Topic 17:00 19:00 High school and students coaching on the different activities : Mind Map
Preliminary Programme Hotel du Lac, Ioannina, Greece (Congress Halls, Main Building) Educational Edition Greece 2014
Organized by: International Symposium Intra Articular Treatment National Foundation of Ultrasound Guided Hip Intra-Articular Therapy (ANTIAGE) www.antiagefbf.it In collaboration with: Rheumatology Clinic,
Challenge to novel bioactive peptides 24 Kenji KANGAWA (National Cerebral and Cardiovascular Center Research Institute, Japan)
Program TUESDAY, SEPTEMBER 10, 2013 15:00 17:00 Registration 17:20 17:30 Opening Remarks: Yoichi UETA 17:30 18:30 Plenary Lecture Chair: Yoichi UETA Challenge to novel bioactive peptides 24 Kenji KANGAWA
31 st Annual Meeting Chicago 2018 Preliminary Program
June 20 June 22, 2019 Northwestern University, Chicago, Illinois USA 15:00-18:00 SLTBR Board Meeting 31 st Annual Meeting Chicago 2018 Preliminary Program Wednesday, June 19 th 8:30-9:00 Registration Thursday,
2018 PITTSBURGH INTERNATIONAL LUNG CONFERENCE Pulmonary Medicine: Basic Biology and Novel Therapies
2018 PITTSBURGH INTERNATIONAL LUNG CONFERENCE Pulmonary Medicine: Basic Biology and Novel Therapies PROGRAM AGENDA Thursday, October 4, 2018 7:00 8:00 am Registration, Refreshments, and Poster Viewing
6 th Hellenic Congress in Athens, of the Hellenic Atherosclerosis Society, on the December 2014
The Cardiovascular Medicine Journal, 2015, 9, 73-77 73 Open Access 6 th Hellenic Congress in Athens, of the Hellenic Atherosclerosis Society, on the 04-06 December 2014 Novel Pharmacologic Treatments of
Saturday, 11th February 2017
Friday, 10th February 2017 Opening Lecture Chairpersons: Karam Kostner and David Colquhoun Lipid Lowering Therapy: Exciting New Developments and Challenges 18:00-19:00 Peter Toth, University of Illinois
SPR Annual Meeting & Postgraduate Course May 15-19, 2018
Tuesday, May 15, 2018 - Postgraduate Course 7:00 AM 8:00 AM Continental Breakfast 7:00 AM 5:30 PM Registration 7:50 AM 8:00 AM Course Overview Postgraduate Course Directors 8:00 AM 8:20 AM General Pediatric
13 th ANNUAL MEETING Siracusa, Sicily, ITALY October 4-6, Hotel des Etrangers Passeggio Adorno 10/12, Siracusa, Italy
13 th ANNUAL MEETING Siracusa, Sicily, ITALY October 4-6, 2015 Hotel des Etrangers Passeggio Adorno 10/12, 96100 Siracusa, Italy OCTOBER 4 th, 2015 Time Event/Speaker Topic 2:00 6:00 pm Registration 3:30
Maintain Cholesterol
Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured
Arteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
International Symposium on the Ehlers-Danlos Syndromes
It is with great pleasure that we invite you to participate in the International Symposium on the Ehlers-Danlos Syndromes September 26 29, 2018 The conference will take place in beautiful Ghent, Belgium,
Cardiovascular Controversies: Emerging Therapies for Lowering Cardiovascular Risk
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
Advances in Cardiovascular Risk Reduction
NYU School of Medicine Continuing Medical Education THE IRWIN D. MANDEL Advances in Cardiovascular Risk Reduction IMPROVING TREATMENT FOR PATIENTS WITH DIABETES Thursday, May 9, 2019 New York, NY nyulmc.org/cvriskcme
Immunological Aspects of Metabolic Syndrome
Immunological Aspects of Metabolic Syndrome August 12-17, 2018 Base Village Conference Center, Snowmass, CO Co-Organizers Suneil Koliwad, MD, PhD UCSF Julie Jameson, PhD CSU San Marcos Dongsheng Cai, MD,
SCIENTIFIC PROGRAM (as of May 9 th, 2018)
SCIENTIFIC PROGRAM (as of May 9 th, 2018) DAY 1 THURSDAY, 07 JUNE 2018 TOPIC: Sarcoidosis 09.30-10.30 "Granuloma Biology Symposium: Etiology and Pathogenesis of Sarcoidosis/ Part A Chairs: D. Culver, P.
Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple